Kimura N, Johnson G S
J Biol Chem. 1983 Oct 25;258(20):12609-17.
A biochemical analysis of an increase in guanine nucleotide-dependent adenylate cyclase activity induced by treatment of cultured SV40-transformed normal rat kidney cells with picolinic acid is described. In purified membranes from drug-treated cells with an ATP regenerating system in assay, GTP- and GTP plus hormone-stimulated adenylate cyclase activities were increased, whereas basal and NaF-stimulated cyclase activities, and steady state rate with guanosine 5'-(beta, gamma-imino)triphosphate were essentially unaltered by drug treatment. In assay systems devoid of ATP regenerating system, the drug-induced increase in cyclase activity was seen with GDP as well as with GTP, it being larger with GDP than with GTP in terms of activity ratio, whereas such an increase was not observed with their analogs, guanosine 5'-O-(2-thiodiphosphate) or guanosine 5'-(beta, gamma-imino)triphosphate. Guanosine 5'-(beta, gamma-imino)triphosphate-stimulated from drug-treated membranes became less sensitive to the inhibition by GDP as shown by a rightward shift in inhibition curve, but this shift could not be reproduced with guanosine 5'-O-(2-thiodiphosphate). From these results, it was concluded that altered guanine nucleotide metabolism in membranes was involved. Neither the amount of guanine nucleotide-binding protein nor its related functions including GTPase activity were changed by drug treatment. However, we observed in the drug-treated cell membranes, an increase in activity of nucleoside diphosphate kinase, an additional factor which has been proposed to play a role in regulating adenylate cyclase by replenishing GTP near the guanine nucleotide binding site (Kimura, N., and Shimada, N. (1983) J. Biol. Chem. 258, 2278-2283). The altered features of adenylate cyclase with the natural guanine nucleotides induced by drug treatment were explained as a result of this enhanced nucleoside diphosphate kinase activity associated with the membranes.
本文描述了用吡啶甲酸处理培养的SV40转化的正常大鼠肾细胞后,鸟嘌呤核苷酸依赖性腺苷酸环化酶活性增加的生化分析。在含有ATP再生系统的药物处理细胞的纯化膜中进行测定时,GTP和GTP加激素刺激的腺苷酸环化酶活性增加,而基础和NaF刺激的环化酶活性以及鸟苷5'-(β,γ-亚氨基)三磷酸的稳态速率基本上不受药物处理的影响。在没有ATP再生系统的测定系统中,用GDP和GTP都能观察到药物诱导的环化酶活性增加,就活性比而言,GDP诱导的增加比GTP诱导的更大,而它们的类似物鸟苷5'-O-(2-硫代二磷酸)或鸟苷5'-(β,γ-亚氨基)三磷酸则未观察到这种增加。药物处理的膜中鸟苷5'-(β,γ-亚氨基)三磷酸刺激的活性对GDP抑制的敏感性降低,表现为抑制曲线向右移动,但用鸟苷5'-O-(2-硫代二磷酸)无法重现这种移动。从这些结果可以得出结论,膜中鸟嘌呤核苷酸代谢发生了改变。药物处理不会改变鸟嘌呤核苷酸结合蛋白的量及其包括GTP酶活性在内的相关功能。然而,我们在药物处理的细胞膜中观察到核苷二磷酸激酶活性增加,这是另一个被认为通过在鸟嘌呤核苷酸结合位点附近补充GTP来调节腺苷酸环化酶的因素(木村,N.,和岛田,N.(1983)《生物化学杂志》258,2278 - 2283)。药物处理诱导的天然鸟嘌呤核苷酸引起的腺苷酸环化酶的改变特征被解释为与膜相关的这种增强的核苷二磷酸激酶活性的结果。